/PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick and Foti, LLC ("KSF"), announces that
BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 26, 2026, to discuss its financial and operating results for the fourth quarter and full year of 2025.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Lantheus Holdings, Inc. (NasdaqGM: LNTH). In August of 2025, contrary to the Company's prior optimistic outlook for the growth potential of its flagship product, Pylarify, the Company disclosed an 8% year-over-year decline in Pylarify revenue, as well as cuts to its full-.
In 1979, the Three Mile Island nuclear power plant suffered a partial nuclear meltdown.
Stanley Laman Group Ltd. raised its holdings in Lantheus Holdings, Inc. (NASDAQ: LNTH) by 38.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 79,686 shares of the medical equipment provider's stock after acquiring an additional 22,229 shares during the quarter.
VIRGINIA RETIREMENT SYSTEMS ET Al cut its stake in Lantheus Holdings, Inc. (NASDAQ: LNTH) by 36.1% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 14,133 shares of the medical equipment provider's stock after selling 8,000 shares during the quarter. VIRGINIA RETIREMENT
BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced it has completed the previously announced sale of its single photon emission computed tomography (SPECT) business to SHINE Technologies, LLC, a subsidiary of Illuminated Holdings, Inc. (collectively, “SHINE”). Under the terms of the agreement, SHINE has acquired Lantheus' SPECT business, including its diagnostic agents (TechneLite® (Technetium Tc 99m generator), NEUROLITE® (Kit for the Preparation of Technetium Tc 99m Bicisate for Injection), Xenon Xe-133 Gas (Xenon Xe-133 Gas), and Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection)), the portion of the North Billerica, Massachusetts campus that manufactures Lantheus' SPECT products, and the SPECT-related Canadian operations.
Osaic Holdings Inc. raised its holdings in shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) by 218.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,177 shares of the medical equipment provider's stock after buying an additional 15,900 shares during
E. Ohman J or Asset Management AB lifted its stake in shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) by 56.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,238 shares of the medical equipment provider's stock after acquiring an
New York City-based Nitorum Capital sold 344,444 shares of Lantheus Holdings in the third quarter. The net position change was approximately $28.2 million from the previous period.
